Latest News

ORIC Pharmaceuticals (ORIC) came under pressure after Ipsen pulled cancer drug Tazverik over concerns about secondary hematologic malignancies, even though ORIC said its prostate cancer candidate rinzimetostat showed no malignancies in preclinical toxicity testing. See our latest analysis for ORIC Pharmaceuticals. At a share price of US$11.90, ORIC has seen a 19.12% 30 day share price return and 45.65% year to date. The 1 year total shareholder return of 52.76% and 3 year total shareholder...

Boeing (BA) is back in the spotlight after disclosing minor electrical wiring damage on undelivered 737 MAX jets, a quality issue that has weighed on the share price despite steady full year delivery guidance. See our latest analysis for Boeing. Those wiring disclosures have fed into recent share price weakness, with Boeing’s 7 day share price return of 9.18% and 30 day return of 13.61% standing in contrast to a 1 year total shareholder return of 29.71%. This suggests momentum has cooled in...

Simmons First National (NasdaqGS:SFNC) reported quarterly results that exceeded revenue and EPS expectations. The bank highlighted resilient operations and solid performance within its regional banking footprint. The update adds fresh information on the company’s current business momentum that has not been reflected in recent coverage. Simmons First National, trading at $18.61, has delivered a quarter that came in ahead of both revenue and earnings forecasts, which puts a fresh spotlight on...

Recently, Wolfe Research began covering GFL Environmental with an Outperform rating while the company renewed its 2026 share buyback program, authorizing repurchases of up to 10% of its public float. Together, the upbeat analyst coverage and renewed buyback underline growing confidence in GFL’s improving operations, balance sheet progress, and merger-and-acquisition driven growth agenda. Next, we’ll examine how the renewed share buyback program could reshape GFL Environmental’s existing...

Recent share performance context Ross Stores (ROST) has drawn investor attention after its shares delivered a 68.3% total return over the past year, along with a 12.9% gain year to date and a 12% return in the past 3 months. See our latest analysis for Ross Stores. At a share price of US$206.28, Ross Stores has recently eased back over the past week even after a solid 30 day share price return, while its 1 year total shareholder return of 68.3% and 3 year total shareholder return of 108.6%...

The Mosaic Company recently announced a quarterly dividend of US$0.2200 per share payable on June 2, 2026, while also advancing plans with Rainbow Rare Earths Ltd. to develop the Uberaba rare earths project in Brazil through new processing facilities targeting production by 2030. This move signals Mosaic’s effort to extract more value from its existing phosphate operations by recovering rare earth elements, potentially diversifying revenue beyond traditional fertilizers. Next, we’ll examine...

Context for Shanghai Junshi Biosciences after recent share performance Shanghai Junshi Biosciences (SEHK:1877) has seen mixed share performance recently, with a small gain over the past week but declines over the past month and past 3 months, drawing attention to how its fundamentals line up. For investors tracking the stock longer term, the shares show a negative total return over 3 and 5 years, while the 1 year total return is positive. This can make current pricing and expectations...

This article examines whether Petco Health and Wellness Company, at around US$3.62, may represent a bargain or a value trap by exploring what the current share price might indicate about the business. The stock has recently experienced sharp moves, with returns of 52.1% over the last 7 days, 44.2% over the last 30 days, 27.0% year to date and 51.5% over the last year. However, the 3 year and 5 year returns show declines of 63.1% and 84.4%, which tells a very different story. These swings...

In late 2025, Corcept Therapeutics received a Complete Response Letter from the FDA rejecting its New Drug Application for relacorilant on the grounds of insufficient evidence of effectiveness, prompting multiple securities class action lawsuits alleging the company misrepresented the drug’s regulatory prospects and prior FDA feedback. These lawsuits focus not just on the setback for relacorilant, but on claims that Corcept withheld repeated FDA concerns while continuing to promote the drug...

Old Republic International (NYSE:ORI) has appointed Doug Wordekemper as CEO of Old Republic Professional. The move is part of a broader organizational leadership change within the Professional division. The appointment brings a leader with extensive industry experience into a key role overseeing the Professional business. Old Republic International, through its Professional division, focuses on specialty insurance solutions for professional liability and related risks. Leadership changes in...

Kyoto Financial Group Inc (TSE:5844) has drawn investor attention after sharply raising its earnings guidance, funded by large gains on equity sales, and pairing that move with a special dividend and expanded share buyback plan. See our latest analysis for Kyoto Financial GroupInc. The flurry of guidance upgrades, special dividend plans and the expanded buyback has coincided with strong recent momentum, with a 30 day share price return of 15.21% and a 1 year total shareholder return of...

Subscriber milestone puts Karooooo (KARO) in focus Cartrack, a subsidiary of Karooooo (KARO), has surpassed two million active subscribers in South Africa. This milestone puts the group’s mobility SaaS model and customer-focused execution firmly on investors’ radar. See our latest analysis for Karooooo. Karooooo’s latest subscriber milestone lands after a period where the share price has moved steadily rather than sharply, with a 5.69% year to date share price return and a 19.93% one year...

If you are wondering whether WEX at around US$159.95 is priced fairly or offering value, you are not alone. This article is built to help you assess that question using several valuation tools. The stock has been relatively mixed recently, with a 7.8% return year to date and 3.8% over the last year, alongside a 4.3% decline over the past week and a 1.4% gain over the last 30 days. These movements can change how the market is thinking about its risk and opportunity. Recent coverage has...

The National Transportation Safety Board plans to hold a hearing on Ford Motor's BlueCruise hands free driving system following two fatal crashes. The hearing will examine how the advanced driver assistance system was used in the incidents and whether additional safety measures are needed. The review puts Ford's automated driving technology and safety practices under closer regulatory and public scrutiny. For investors watching NYSE:F at a current share price of $11.67, this hearing comes...

LKQ stock performance context LKQ (LKQ) shares closed at $29.34, with the stock showing a 1 day return of 1.38% and a 7 day decline of 6.77%. This sets the stage for a closer look at its recent performance. See our latest analysis for LKQ. At the current share price of $29.34, LKQ’s 30 day share price return of a 13.96% decline sits alongside a 1 year total shareholder return of a 26.95% decline, pointing to fading momentum rather than a short term blip. If LKQ’s recent pullback has you...

Capital Power Corporation has reported its full-year 2025 results, with sales of CA$3,615 million and net income of CA$160 million, while also affirming a quarterly common dividend of CA$0.6910 per share and declaring dividends on several series of preferred shares. The sharp decrease in net income and earnings per share from continuing operations compared with the prior year contrasts with the company’s continued dividend payments, raising questions about how management is balancing...

EQ Resources (ASX:EQR) has reported H1 2026 revenue of A$44.0 million with a basic EPS loss of A$0.0017, while trailing twelve month figures show revenue of A$75.4 million and a basic EPS loss of A$0.0067. The company has seen revenue move from A$34.8 million and a basic EPS loss of A$0.0118 in H1 2025 to A$31.5 million and a basic EPS loss of A$0.0060 in H2 2025, before reaching the latest H1 2026 levels. This sets up a story where growing sales are still being weighed against ongoing...

Earlier this month, AT&T announced over US$250.00 billion of planned U.S. connectivity investment through 2030, launched more flexible Unlimited Your Way wireless plans, and issued long-dated Canadian dollar bonds to support its network build-out. Together, these moves highlight AT&T’s push to reposition itself as a core connectivity platform for AI-era data demand while sharpening its consumer value proposition. Now we’ll examine how AT&T’s US$250.00 billion connectivity build-out plan...

Why Celldex Therapeutics (CLDX) is on investors’ radar today Celldex Therapeutics (CLDX) has drawn attention after recent trading, with shares last closing at $29.51 and showing mixed returns over the past week, month, past 3 months, and year. See our latest analysis for Celldex Therapeutics. Recent trading has been choppy, with a 30 day share price return of 28.30% and a 1 year total shareholder return of 44.52%, set against a weaker 3 year total shareholder return of 29.47% and a 5 year...

Recent share performance and business snapshot Titan America (TTAM) has drawn attention after a one month return showing a 16.1% decline, extending a past 3 months slide of 7.8%. This has prompted investors to reassess the cement and building materials producer. The Brussels based company reports annual revenue of US$1.65b and net income of US$178.46m, with recent revenue growth of 6.3% and net income growth of 13.7%. This has put a spotlight on how earnings support the current share...

G-III Apparel Group has reported a weaker fourth quarter for fiscal 2026, with sales falling to US$771.49 million and a net loss of US$31.94 million, while also guiding to lower near-term revenue and earnings as it exits Calvin Klein and Tommy Hilfiger licenses and absorbs charges related to the Saks Global bankruptcy. Alongside these softer results, the company reaffirmed its portfolio shift toward higher-margin owned brands, announced a US$0.10 quarterly dividend, and outlined a US$25...

PENN Entertainment (PENN) is back on investors’ radar after announcing a 203-room hotel tower and an expanded high-limit table games room at Hollywood Casino Columbus, both pending regulatory approvals. See our latest analysis for PENN Entertainment. Despite the hotel and high limit room expansion plans and the recent earnings surprise in Q4 2025, sentiment around PENN has been mixed. A 21.68% 1 month share price return contrasts with a 16.27% 1 year total shareholder return decline and an...

Birchcliff Energy confirmed record annual production and a material cut in indebtedness. The company reported a successful well flow test alongside broader operational updates. Birchcliff outlined plans for a new natural gas processing plant, adding to its infrastructure build out. For investors watching TSX:BIR, this mix of record production and lower debt comes alongside a share price of CA$7.19 and a 27.5% return over the past year. The stock has also delivered a 212.4% return over five...

Imperial Metals Corporation recently reported its full-year 2025 results, with sales rising to C$691.78 million and net income reaching C$153.78 million, lifting basic earnings per share from continuing operations to C$0.91. Alongside record revenue and a stronger balance sheet, the company highlighted higher-end gold and copper production and continued progress on the Red Chris block cave expansion project. We’ll now consider how this combination of record revenue and advancing Red Chris...